Clinical Operations Executive
Doctor of Pharmacy · Chandler, AZ
A Pharm.D. who has personally directed 20+ concurrent trials, administered $180M in program budgets, and co-authored the ASCO presentations that made those programs matter — bringing scientific authority to operations that most organizations have never seen in a single person.
Career Highlights
As Global Clinical Ops lead for Celgene's Hematology/Oncology division, administered $180M across 8 compounds and 20 simultaneous studies while mentoring 8 Senior Study Managers across three regional offices. The proof point: opening 3 trials for accrual within 9 weeks of final protocol delivery. The industry benchmarks this at 4–6 months.
Led global ops for a precision oncology program targeting adenoid cystic carcinoma — a rare cancer with no approved treatments and a narrow biomarker-selected patient pool at a handful of specialist centers worldwide. Engineered the site feasibility and recruitment strategy that made multinational accrual viable at all, where standard playbooks didn't apply.
Joined Indaptus as the first clinical ops executive and built the entire function from scratch — SOPs, CRO framework, TMF, oversight architecture — while simultaneously running a Phase I/II IO program through dose escalation. Then co-authored 10+ peer-reviewed publications at ASCO, SITC, and AACR. Most ops executives do one of these things.
The Pharm.D. Difference
Most clinical ops executives understand the process. Jeffery understands the science behind it. A doctoral-level pharmacist who interrogates data, challenges protocol assumptions, and contributes to the regulatory narrative — not just executes it.
That distinction changes what he can do for a CMO or scientific founder. He doesn't need the science translated. He can sit across from a KOL, discuss mechanism of action, evaluate a site's patient population, and make enrollment decisions grounded in both operational reality and clinical judgment.
It's why he has been the author, not just the signatory, on presentations at ASCO, SITC, and AACR throughout his career — contributing original scientific thinking alongside the teams whose programs he operationalizes.
"An unusually high scientific footprint for an executive whose primary role is clinical operations."
Professional Experience
Built and led the clinical operations function for a clinical-stage immuno-oncology biotech — establishing the entire infrastructure from scratch while overseeing a Phase I/II program through dose escalation and expansion.
Led global clinical operations for a Precision Medicine-focused oncology biotech targeting a rare disease indication — where a narrow biomarker-selected patient population demanded a sophisticated multinational site strategy.
Directed simultaneous programs across immuno-oncology, orphan disease, and rheumatology — one of the broadest multi-indication portfolios managed by a single ops leader at the company over a five-year tenure.
Hand-selected to lead strategic lifecycle planning for two of the three highest-priority global oncology compounds, managing a 14-person team across design, execution, and evaluation.
Global Clinical Operations lead for the Hematology/Oncology portfolio — 8 compounds, 20 concurrent studies, $180M in programmatic assets.
Earlier Career
Divisional Deputy Director — bench-to-bedside translational oncology research; Stand Up 2 Cancer grant recipient.
Associate Director, Clinical Development — Medical Affairs lead for Anti-infective and Oncology; IND submissions.
Director, Translational Oncology — Phase I/II business development; national physician research network.
Sr. Director & Clinical Research Manager — 4 proprietary oncology products; pivotal Phase III global trials.
Complete career history available upon request.
Credentials
Resume
Formatted for executives and search firms.
Full career detail on the Experience page.